Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Werner J. Struss"'
Autor:
Alexander W. Wyatt, Peter C. Black, Bernhard J. Eigl, Colin C. Collins, Arnulf Stenzl, Scott North, Kim N. Chi, Matti Nykter, Jörg Hennenlotter, Stanislav V. Volik, Sonal Brahmbhatt, Elie Ritch, Kevin Beja, Amanda Wong, Werner J. Struss, Matti Annala, Tilman Todenhöfer, Gillian Vandekerkhove
Excel file with all five supplemental tables, each contained on a separate tab. Table S1 describes the patient cohort and clinical characteristics. Table S2 describes the targets of our custom sequencing approach. Table S3 relates cfDNA yields and su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14632e62c793b2cc6559d63a2c9f2983
https://doi.org/10.1158/1078-0432.22468124.v1
https://doi.org/10.1158/1078-0432.22468124.v1
Autor:
Alexander W. Wyatt, Peter C. Black, Bernhard J. Eigl, Colin C. Collins, Arnulf Stenzl, Scott North, Kim N. Chi, Matti Nykter, Jörg Hennenlotter, Stanislav V. Volik, Sonal Brahmbhatt, Elie Ritch, Kevin Beja, Amanda Wong, Werner J. Struss, Matti Annala, Tilman Todenhöfer, Gillian Vandekerkhove
Purpose: Targeted agents and immunotherapies promise to transform the treatment of metastatic bladder cancer, but therapy selection will depend on practical tumor molecular stratification. Circulating tumor DNA (ctDNA) is established in several solid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f173e36236b3de48bc3ebff929dbc97
https://doi.org/10.1158/1078-0432.c.6526847.v1
https://doi.org/10.1158/1078-0432.c.6526847.v1
Autor:
Alexander W. Wyatt, Peter C. Black, Bernhard J. Eigl, Colin C. Collins, Arnulf Stenzl, Scott North, Kim N. Chi, Matti Nykter, Jörg Hennenlotter, Stanislav V. Volik, Sonal Brahmbhatt, Elie Ritch, Kevin Beja, Amanda Wong, Werner J. Struss, Matti Annala, Tilman Todenhöfer, Gillian Vandekerkhove
Methods for blood processing and DNA isolation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb4a5132fe4e1fb6a21d4169acc1fc8
https://doi.org/10.1158/1078-0432.22468127
https://doi.org/10.1158/1078-0432.22468127
Autor:
Alexander W. Wyatt, Peter C. Black, Bernhard J. Eigl, Colin C. Collins, Arnulf Stenzl, Scott North, Kim N. Chi, Matti Nykter, Jörg Hennenlotter, Stanislav V. Volik, Sonal Brahmbhatt, Elie Ritch, Kevin Beja, Amanda Wong, Werner J. Struss, Matti Annala, Tilman Todenhöfer, Gillian Vandekerkhove
File containing all 13 supplementary figures, complete with figure legends.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4675c706326513ee23b56aca3bc4894
https://doi.org/10.1158/1078-0432.22468130.v1
https://doi.org/10.1158/1078-0432.22468130.v1
Autor:
Martin E. Gleave, Alan So, Heini Kallio, Matti Nykter, Cameron Herberts, Yulia Loktionova, Werner J. Struss, Daniel Khalaf, Teuvo L.J. Tammela, Gillian Vandekerkhove, Evan W. Warner, Kim N. Chi, Peter C. Black, Elie Ritch, Kevin Beja, Alexander W. Wyatt, Ladan Fazli, Antonio Hurtado-Coll, Matti Annala
Publikováno v:
European Urology. 75:667-675
Background Several systemic therapeutic options exist for metastatic castrate-sensitive prostate cancer (mCSPC). Circulating tumor DNA (ctDNA) can molecularly profile metastatic castration-resistant prostate cancer and can influence decision-making,
Autor:
Jonathan Dyer, C. Marsh, Werner J. Struss, Kevin Hamer, A. Garrett, Bhaskar K. Somani, Tim Dudderidge, Edmund C.P. Chedgy
Publikováno v:
European Urology Open Science, Vol 19, Iss, Pp e241-e242 (2020)
Autor:
Tim Dudderidge, Jonathan Dyer, Claire Marsh, Werner J. Struss, Bhaskar K. Somani, Kevin Hamer, Anthony Garrett, Edmund C.P. Chedgy
Publikováno v:
Journal of Urology. 203
Autor:
Kim N. Chi, Sunil Parimi, Edmund Cp Chedgy, Saki Konomura, Joanna Vergidis, Matti Annala, Gillian Vandekerkhove, Alexander W. Wyatt, Andrea Sboner, Adam J. Donoghue, Werner J. Struss, Elie Ritch, Cameron Herberts, Antonio Hurtado-Coll, Ladan Fazli, Himisha Beltran, Janet Liew, Michael Sigouros
Publikováno v:
The Journal of Pathology. 246:244-253
Small-cell prostate carcinoma (SCPC) is an aggressive malignancy that is managed similarly to small-cell lung cancer. SCPC can evolve from prostate adenocarcinoma in response to androgen deprivation therapy, but, in rare cases, is present at initial
Publikováno v:
Bladder Cancer (Amsterdam, Netherlands)
Todenhöfer, Tilman; Struss, Werner J; Seiler, Roland; Wyatt, Alexander William; Black, Peter C (2018). Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer. Bladder cancer, 4(1), pp. 19-29. IOS Press 10.3233/BLC-170140
Todenhöfer, Tilman; Struss, Werner J; Seiler, Roland; Wyatt, Alexander William; Black, Peter C (2018). Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer. Bladder cancer, 4(1), pp. 19-29. IOS Press 10.3233/BLC-170140
Recent advances in DNA profiling techniques have enabled sensitive detection of tumor-associated genomic aberrations in peripheral blood. This type of minimally-invasive molecular interrogation has the potential to guide subsequent treatment selectio
Autor:
Mu Chiao, Alan I. So, Sebastian Frees, Zheng Tan, Claudia Chavez-Munoz, John K. Jackson, Werner J. Struss, Ali Shademani, Igor Moskalev, Ninadh M. D'Costa, Peter A. Raven, Payam Zachkani
Publikováno v:
The Prostate. 77:1356-1365
Background The vast majority of prostate cancer presents clinically localized to the prostate without evidence of metastasis. Currently, there are several modalities available to treat this particular disease. Despite radical prostatectomy demonstrat